Gilford Securities Issues Research Report on Eastman Chemical (EMN)
Gilford Securities, a full-service investment firm, headquartered in New York City, announced a change in recommendation on Eastman Chemical (EMN) downgrading their previous Buy rating to a Hold rating in a research report issued to clients.
- New York, NY (1888PressRelease) October 13, 2012 - The Gilford Securities analyst noted, "We are not negative, (valuation has only recovered from low to fair), only more cautious." Commenting on the reasons for the downgrade, the analyst cited three reasons for the change in rating:
"First, since January we have felt that the Solutia acquisition is expensive. In particular, we think 10x EBITDA is a full price for a business that has already been put through the cost-cutting wringer, making $100mm in cost synergies by year-end 2013 look ambitious, and that gets most of its earnings from one product (Crystex vulcanizing agent in radial tires). The investment community, meanwhile, is already quite positive."
"Second, we see the possibility of an earnings shortfall. For 2H12 and 2013, we get slightly below consensus numbers, and we might be high. In particular, Solutia." The analyst also noted "the shortfall appears to be mainly in Advanced Interlayers, (SAFLEX windshield interlayer, VISTASOLAR photovoltaic encapsulants). Solar and Europe remaining under pressure might mean 2H EBITDA below 1H."
As a third reason for the downgrade, "Our two long-term growth stories might be taking a little longer to ripen. The first was Tritan packaging copolyester, which we wrote up in 2010; second, Perennial acetylated wood, which we highlighted a year ago. Both these projects are on track but Tritan is taking longer than expected to sell up its capacity, and Perennial is in an early marketing stage at big box stores, so there may be another three years or so to wait. The same is true of the benefits to Eastman of a deal agreed earlier this year with Enterprise to buy propylene from it at propane-plus pricing once its propane dehydrogenation unit starts up around mid-2015."
About Gilford Securities
Founded in 1979 by senior officers of the former Blythe Eastman Dillon & Co., Gilford Securities is a full-service boutique investment firm providing an array of financial services to institutional and retail clients including corporate finance services, independent equity research, equity sales and trading, retirement planning and wealth management. The firm's research effort targets select underserved niche segments in the small and middle capitalization market sector.
For more information about Gilford Securities, please visit http://www.gilfordsecurities.com
Contact:
Robert Maley, President, Gilford Securities Incorporated
212-888-5342
Robert.maley ( @ ) gilfordsecurities dot com
Analyst Certification
Each analyst named on a Gilford Securities research report certifies the research report accurately reflects the personal views of the analyst regarding the subject companies and certifies that the analyst has not and will not receive compensation with respect to the issuance of the report.
Required Disclosures
In the normal course of business, Gilford Securities seeks to perform investment banking and other services for various companies and to receive compensation in connection with such services. As such, Gilford Securities intends to seek compensation for investment banking services from the subject company in the next three months.
Gilford Securities Stock Ratings
Buy: The stock should outperform its industry or peer group by 20% or greater within a 12-month timeframe.
Sell: The stock is expected to underperform its industry or peer group by 20% or greater within a 12-month timeframe, or fundamentals have deteriorated significantly and the stock is expected to materially deteriorate.
Hold: The stock does not have enough upside or downside potential to rate it a Buy or Sell. It is either fairly valued or carries too much uncertainty for a Buy or Sell Rating.
###
space
space